UBS AM Portfolio holdings
UBS Asset Management (UBS AM), a division of UBS Group AG with origins tied to the bank’s founding in 1862, is headquartered in Zurich, Switzerland, and manages hundreds of billions in assets for institutional, intermediary, and wealth management clients globally. Specializing in a broad range of investment strategies—including equities, fixed income, multi-asset, alternatives, and sustainable investing—UBS AM leverages the firm’s extensive research capabilities and global network to deliver tailored solutions. Known for its focus on risk management and innovation, it offers products like ETFs, index funds, and private market investments, catering to diverse needs from pension funds to high-net-worth individuals. As part of UBS’s broader ecosystem, UBS AM combines Swiss precision with a commitment to ESG principles, solidifying its position as a leader in the asset management industry.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$498M |
| 2 |
Ametek
AME
|
+$445M |
| 3 |
Microsoft
MSFT
|
+$432M |
| 4 |
Apple
AAPL
|
+$209M |
| 5 |
Tesla
TSLA
|
+$198M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amgen
AMGN
|
+$759M |
| 2 |
Accenture
ACN
|
+$529M |
| 3 |
ConocoPhillips
COP
|
+$392M |
| 4 |
iShares Core S&P Total US Stock Market ETF
ITOT
|
+$324M |
| 5 |
iShares Core S&P Small-Cap ETF
IJR
|
+$310M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.01% |
| 2 | Healthcare | 15.34% |
| 3 | Financials | 12.73% |
| 4 | Consumer Discretionary | 9.85% |
| 5 | Industrials | 8.51% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1076
Applied Industrial Technologies
AIT
$13.3B
| $5.67M | ﹤0.01% |
44,952
+587
| +1% | +$72K |
|
1077
Ultragenyx Pharmaceutical
RARE
$2.55B
| $5.65M | ﹤0.01% |
121,919
+23,282
| +24% | +$916K |
|
1078
Integra LifeSciences
IART
$1.34B
| $5.64M | ﹤0.01% |
100,650
+8,741
| +10% | +$445K |
|
1079
iQIYI
IQ
$1.28B
| $5.61M | ﹤0.01% |
1,058,383
-51,028
| -5% | -$149K |
|
1080
Bank of Hawaii
BOH
$3.13B
| $5.6M | ﹤0.01% |
72,240
+5,400
| +8% | +$419K |
|
1081
Natera
NTRA
$46.4B
| $5.58M | ﹤0.01% |
138,916
+22,405
| +19% | +$923K |
|
|
AL
1082
DELISTED
Air Lease Corp
AL
| $5.57M | ﹤0.01% |
145,030
-9,595
| -6% | -$345K |
|
|
LHCG
1083
DELISTED
LHC Group LLC
LHCG
| $5.56M | ﹤0.01% |
34,399
-57,162
| -62% | -$9.44M |
|
1084
Armstrong World Industries
AWI
$7.84B
| $5.56M | ﹤0.01% |
81,026
+1,534
| +2% | +$116K |
|
1085
Saia
SAIA
$9.72B
| $5.55M | ﹤0.01% |
26,457
+3,213
| +14% | +$700K |
|
1086
Silicon Laboratories
SLAB
$7.23B
| $5.54M | ﹤0.01% |
40,848
-2,032
| -5% | -$267K |
|
1087
Flowserve
FLS
$10.2B
| $5.54M | ﹤0.01% |
180,487
+12,161
| +7% | +$355K |
|
1088
Yeti Holdings
YETI
$3.95B
| $5.53M | ﹤0.01% |
133,771
+1,790
| +1% | +$67.2K |
|
|
LNW
1089
DELISTED
Light & Wonder
LNW
| $5.46M | ﹤0.01% |
93,191
-199,517
| -68% | -$11.4M |
|
1090
First Hawaiian
FHB
$3.35B
| $5.44M | ﹤0.01% |
208,750
+9,276
| +5% | +$238K |
|
|
SYNH
1091
DELISTED
Syneos Health, Inc. Class A Common Stock
SYNH
| $5.41M | ﹤0.01% |
147,589
-303
| -0.2% | -$12K |
|
1092
Old National Bancorp
ONB
$10.2B
| $5.4M | ﹤0.01% |
300,563
+7,479
| +3% | +$137K |
|
|
STER
1093
DELISTED
Sterling Check Corp. Common Stock
STER
| $5.39M | ﹤0.01% |
348,393
+22,313
| +7% | +$360K |
|
1094
Chord Energy
CHRD
$7.39B
| $5.38M | ﹤0.01% |
39,344
-5,409
| -12% | -$793K |
|
|
NXRT
1095
NexPoint Residential Trust
NXRT
$652M
| $5.35M | ﹤0.01% |
122,928
+2,444
| +2% | +$109K |
|
1096
The Ensign Group
ENSG
$10.7B
| $5.31M | ﹤0.01% |
56,100
-718
| -1% | -$65.1K |
|
1097
IPG Photonics
IPGP
$3.84B
| $5.29M | ﹤0.01% |
55,876
-19,734
| -26% | -$1.77M |
|
1098
Travel + Leisure Co
TNL
$4.7B
| $5.29M | ﹤0.01% |
145,310
-2,869
| -2% | -$107K |
|
1099
Southwest Gas
SWX
$6.67B
| $5.29M | ﹤0.01% |
85,461
-5,339
| -6% | -$363K |
|
1100
Exponent
EXPO
$3.24B
| $5.28M | ﹤0.01% |
53,332
+2,775
| +5% | +$270K |
|
Similar funds
UBS AM's Q4 2022 Portfolio in Review
As of Q4 2022, UBS AM held 2,824 positions worth $191B, up 7% from $178B the previous quarter. Its ten largest holdings account for 19% of the portfolio.
UBS AM's Q4 2022 filing shows 88 new, 1,334 increased, 722 reduced and 301 closed positions. Its largest new stake was Ferguson: 543,379 shares worth $69M. The largest sale was Amgen, an estimated $759M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, down from 26% a quarter earlier, followed by Healthcare and Financials.
- UBS AM's largest Q4 2022 buy was Ferguson: 543,379 shares worth $69M.
- UBS AM added most to Amazon in Q4 2022, an estimated $498M increase.
- UBS AM's biggest Q4 2022 reduction was Accenture, cutting an estimated $529M.
- UBS AM fully exited Amgen in Q4 2022, selling an estimated $759M.
- UBS AM's ten largest holdings make up 19% of its $191B portfolio in Q4 2022.
- UBS AM opened 88 new positions and closed 301 in Q4 2022.
- UBS AM's portfolio value rose 7% quarter-over-quarter to $191B.
Based on UBS AM's 13F filing for Q4 2022, filed 14 Feb 2023.